Shares of Ambu A/S (OTCMKTS:AMBBY - Get Free Report) traded up 5.3% on Thursday . The company traded as high as $17.57 and last traded at $17.57. 200 shares changed hands during mid-day trading, a decline of 47% from the average session volume of 380 shares. The stock had previously closed at $16.69.
Ambu A/S Price Performance
The company has a market cap of $4.13 billion and a P/E ratio of 103.35. The firm's 50-day moving average is $18.44 and its two-hundred day moving average is $17.60. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.60 and a quick ratio of 1.47.
Ambu A/S (OTCMKTS:AMBBY - Get Free Report) last released its quarterly earnings results on Thursday, January 30th. The company reported $0.10 EPS for the quarter. Ambu A/S had a return on equity of 5.67% and a net margin of 5.69%.
About Ambu A/S
(
Get Free Report)
Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.
Further Reading
Before you consider Ambu A/S, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ambu A/S wasn't on the list.
While Ambu A/S currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
